Pro Medicus Limited (OTCMKTS:PMCUF) Short Interest Update

Pro Medicus Limited (OTCMKTS:PMCUF) was the recipient of a large drop in short interest in February. As of February 27th, there was short interest totaling 401,116 shares, a drop of 19.9% from the February 12th total of 500,825 shares. Based on an average daily volume of 378 shares, the days-to-cover ratio is currently 1,061.2 days. Based on an average daily volume of 378 shares, the days-to-cover ratio is currently 1,061.2 days.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group set a $155.00 target price on shares of Pro Medicus and gave the stock a “buy” rating in a research report on Thursday, February 12th. One analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the company has a consensus rating of “Buy” and an average target price of $155.00.

Pro Medicus Price Performance

OTCMKTS:PMCUF opened at $94.03 on Friday. The company has a 50 day moving average price of $109.42 and a 200-day moving average price of $152.28. Pro Medicus has a 1-year low of $74.52 and a 1-year high of $218.25.

Pro Medicus Company Profile

Pro Medicus Limited is an Australia‐based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.

The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.